ECHOGUIDED PERCUTANEOUS NEUROMODULATION

WHAT IS PERCUTANEOUS ULTRASOUND-GUIDED NEUROMODULATION (PNS)?

Peripheral Neuromodulation: A Review: Teodor Goroszeniuk ; David Pang) is a technique consisting of introducing acupuncture needles or dry needling in the vicinity of the peripheral nerve, connected to a PENS or PENS BURST type electrical current device that allows different parameters such as frequency, pulse width and intensity to be adjusted in order to obtain an electrical signal in a more selective and effective manner.

As for the procedure, it is applied to different neural structures in relation to a previous evaluation of the patient’s symptomatology and dysfunction, in order to promote changes in the peripheral and central nervous system, modulating the abnormal behaviour of the neural pathway caused by the disease process.

The application must be performed in an ultrasound-guided manner in order to be precise and safe during the needle insertion process and subsequent treatment, as well as with a device with a health certificate for this intended use, as in the case of EPTE® Bipolar System

BENEFITS OF PERCUTANEOUS ULTRASOUND-GUIDED NEUROMODULATION

The introduction of this technique in clinical practice allows to accelerate recovery times, being useful once the injury is established, as well as in a preventive approach to dysfunction.

Ultrasound-guided percutaneous neuromodulation makes it possible to work directly on the dysfunctional nervous system, improving short-term pain, as well as other symptoms present in the disease.

For the correct application of percutaneous neuromodulation, it is necessary to have previous training in ultrasound, as well as knowledge of basic anatomy and clinical practice in invasive techniques.

NMP APPLICATIONS

The applications of percutaneous neuromodulation in the following fields are worth mentioning:

  • the treatment of acute and chronic pain of musculoskeletal origin such as lumbar pain, postoperative pain, neuropathic pain, chronic cervical pain of myofascial origin, TMJ, among others.
  • restore the function of the nervous system, at peripheral and central levels, in aspects related to sensory or motor dysfunction.
  • improve neuromuscular function, muscle recruitment patterns and motor control.

The EPTE® Bipolar System devices which allows the application of this technique has CE health certificate.

Endogenous and safe neuromodulation application, how and why . New EPTE® Bipolar System devices allows the application of percutaneous neuromodulation therapy in this way.

NOT RECOMMENDED in the following cases:

because of the risks associated with the invasive technique and the passage of current (*to be assessed by each practitioner, within a specific clinical context).

  • Infectious arthritis.
  • Cardiopathies / Cardiac arrhythmias.
  • Pregnancy.
  • Skin ulcers and other skin infections.
  • Endoprosthesis and/or osteosynthesis in the area of application.
  • Pacemakers.
  • Oncological processes.
  • Thrombophlebitis / History of vascular insufficiency in the leg.
  • Blood dyscrasias.
  • Menstruation.
  • Needle phobia.
  • Fear of electrical stimulation.
  • Application in endocrine glands.
  • Patients with altered sensitivity.
  • Patients with neurological alterations of central and peripheral origin.
  • Patients with neurovegetative disorders.
  • Paediatric patients (under 14 years of age).
  • Complicated medical conditions.
  • Cognitive impairment.
  • Drug or alcohol abuse.

PERCUTANEOUS ULTRASOUND-GUIDED PERCUTANEOUS NEUROMODULATION APPLICATION DEVICE

EPTE® Bipolar System is the first device on the market with CE for the application of NMP_Neuromodulation Percutaneous Echoguided Percutaneous Neuromodulation (NMP)

Online Assistance